SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-009072
Filing Date
2014-02-11
Accepted
2014-02-11 15:54:38
Documents
1
Period of Report
2014-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5365
  Complete submission text file 0001209191-14-009072.txt   7115
Mailing Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116
Business Address
GADICKE ANSBERT (Reporting) CIK: 0001134655 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35945 | Film No.: 14594241

Mailing Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 54TH STREET BOSTON MA 02116
Business Address
EVNIN LUKE (Reporting) CIK: 0001134657 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35945 | Film No.: 14594242

Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Issuer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations